IHE icon

iShares US Pharmaceuticals ETF

127 hedge funds and large institutions have $127M invested in iShares US Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$421K
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$5.64M
2 +$4.27M
3 +$3.8M
4
Jane Street
Jane Street
New York
+$2.35M
5
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$1.46M

Top Sellers

1 -$8.21M
2 -$5.35M
3 -$3.73M
4
Citadel Advisors
Citadel Advisors
Florida
-$3.59M
5
Morgan Stanley
Morgan Stanley
New York
-$1.7M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.7M
2
$11.2M
3
$8.03M
4
$6.76M
5
$6.6M
6
$6.49M
7
$5.64M
8
$5.29M
9
$5.03M
10
$4.91M
11
$4.43M
12
$3.82M
13
$3.19M
14
$3.16M
15
$2.73M
16
$2.35M
17
$2.16M
18
$1.91M
19
$1.51M
20
$1.28M
21
$1.24M
22
$1.12M
23
$1.11M
24
$1.08M
25
$1.03M